礼来将收购疫苗公司以推进抗EB病毒等传染病的顶尖候选疫苗

美股速递
May 26

为推进针对EB病毒及其他传染病的顶尖候选疫苗研发,礼来公司宣布将收购一家疫苗公司。此举旨在整合资源与技术,加速相关疫苗管线的开发进程,以应对当前未满足的医疗需求。此次收购预计将增强礼来在传染病疫苗领域的研发实力,并为其产品组合带来新的增长潜力。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10